Alzheimer's disease: a 'cobalaminergic' hypothesis

Area of Science:

• Neurology
• Biochemistry
• Nutritional Science

Background:

• Recent studies indicate an association between Alzheimer's Disease (AD) and reduced levels of vitamin B12 (cobalamin) in cerebrospinal fluid (CSF) and serum.
• This association appears to be independent of dietary vitamin B12 intake.
• Some research suggests that affected individuals may present with an atypical form of cobalamin deficiency.

Purpose of the Study:

• To propose that vitamin B12 deficiency may play an etiological role in specific subgroups of Alzheimer's Disease.
• To describe a potential mechanism linking vitamin B12 deficiency to the characteristic neurotransmitter alterations observed in AD.
• To generate predictions for biochemical evaluations and suggest correlations between neurochemical disturbances and structural abnormalities in AD.

Main Methods:

• Literature review and hypothesis formulation based on existing associations.
• Proposed mechanism linking cobalamin deficiency to neurotransmitter changes.
• Generation of testable predictions for biochemical and structural assessments in AD patients.

Main Results:

• Established association between low vitamin B12 (cobalamin) and Alzheimer's Disease.
• Hypothesized an atypical cobalamin deficiency in some AD patients.
• Proposed a mechanism for B12 deficiency impacting neurotransmitters in AD.

Conclusions:

• Vitamin B12 deficiency may be an important etiological factor in certain Alzheimer's Disease populations.
• The proposed mechanism provides a biochemical link between cobalamin status and AD neuropathology.
• Further research is warranted to explore the diagnostic and therapeutic implications of vitamin B12 levels in AD.